After a freak accident left him blind and in agony, Phil Durst thought hope was lost. Then, a world-first stem cell trial changed everything.

Serious diseases affecting the transparent part of the eye, called the cornea, are very difficult to treat because this ...

Glaukos Corporation GKOS recently announced the commercial availability of Epioxa, marking a significant milestone in its corneal health portfolio. The therapy stands out as the first FDA-approved, ...

University of Pittsburgh School of Medicine researchers have developed an early-stage, experimental "living eye drop" that ...

Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...

A Bengaluru-based biotech startup is developing a breakthrough solution for corneal damage. Pandorum Technologies’ “Liquid Cornea” could reshape how doctors treat vision loss in the future.

Aurion Biotech today named Dr. Marjan Farid, Director of Cornea, Cataract, and Refractive Surgery and a Clinical Professor at ...

Dry eye has emerged as an early warning sign of autoimmune disease, appearing roughly three years before many patients receive a formal diagnosis. That gap reframes a common irritation as a potential ...